EUVIMEDEUVIMED entdecken
Crossref

Tumor‐Targeting Near‐Infrared Dimeric Heptamethine Cyanine Photosensitizers with an Aromatic Diphenol Linker for Imaging‐Guided Cancer Phototherapy

Yang Xu, Jiaying Yu, Jinzhong Hu, Kai Sun, Wenjun Lu, Fenglian Zeng, Jian Chen, Min Liu, Zhuoer Cai, Xiaofan He, Wanying Wei, Baiwang Sun iD

Advanced Healthcare Materials · 2023

DOI: 10.1002/adhm.202203080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Yang Xu und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Southeast University, Nanjing, 210000, China. Hauptthemen laut MEDLINE: Photochemotherapy, Neoplasms, Nanoparticles. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phototherapy is considered a promising alternative to conventional tumor treatments due to its noninvasive modality and effective therapeutic effect. However, designing a photosensitizer with satisfactory therapeutic effect and high security remains a considerable challenge. Herein, a series of dimeric heptamethine cyanine photosensitizers with an aromatic diphenol linker at the meso position is developed to improve the photothermal conversion efficiency (PCE). Thanks to the extended conjugate system and high steric hindrance, the screened 26NA‐NIR and 44BP‐NIR exhibit high PCE (≈35%), bright near‐infrared (NIR) fluorescence, excellent reactive oxygen species (ROS) generation capability, and improved photostability. Furthermore, their outstanding performance on imaging‐guided PDT–PTT synergistic therapy is demonstrated by in vivo and in vitro experiments. In conclusion, this study designs a series of dimeric heptamethine cyanine photosensitizers and presents two compounds for potential clinical applications. The strategy provides a new method to design NIR photosensitizers for imaging‐guided cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyNeoplasmsNanoparticlesHumansPhotosensitizing AgentsPhototherapyPolymersCell Line, Tumor

Stichwörter der Autor:innen

aromatic diphenolcyaninedimeric photosensitizersnear-infraredphototherapy

Substanzen

Photosensitizing AgentsPolymers

Autor:innen und Institutionen

  • School of Chemistry and Chemical Engineering, Southeast University, Nanjing, 210000, China.

ORCID-Profile: Baiwang Sun

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Xu, Y., Yu, J., Hu, J., Sun, K., Lu, W., Zeng, F., Chen, J., Liu, M., Cai, Z., He, X., Wei, W., & Sun, B. (2023). Tumor‐Targeting Near‐Infrared Dimeric Heptamethine Cyanine Photosensitizers with an Aromatic Diphenol Linker for Imaging‐Guided Cancer Phototherapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202203080

Vancouver

Xu Y, Yu J, Hu J, Sun K, Lu W, Zeng F, et al. Tumor‐Targeting Near‐Infrared Dimeric Heptamethine Cyanine Photosensitizers with an Aromatic Diphenol Linker for Imaging‐Guided Cancer Phototherapy. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202203080

BibTeX
@article{Xu2023,
  author = {Xu, Yang and Yu, Jiaying and Hu, Jinzhong and Sun, Kai and Lu, Wenjun and Zeng, Fenglian and Chen, Jian and Liu, Min and Cai, Zhuoer and He, Xiaofan and Wei, Wanying and Sun, Baiwang},
  title = {Tumor‐Targeting Near‐Infrared Dimeric Heptamethine Cyanine Photosensitizers with an Aromatic Diphenol Linker for Imaging‐Guided Cancer Phototherapy},
  journal = {Advanced Healthcare Materials},
  year = {2023},
  doi = {10.1002/adhm.202203080}
}
Kostenlos starten →